Health Care Services: Improving Foreign Patient Revenue Appears Largely Priced In
We maintain our Neutral rating on the healthcare sector based on four key factors: i) the lack of company-specific catalysts that could drive share...
115 Views
APAC Healthcare Weekly (April 19) – Fosun Pharma, Remegen, Daiichi Sankyo, Astellas Pharma, Telix
FDA granted Priority Review to Daiichi Sankyo’s I-DXd. Astellas Pharma initiates Phase 3 study for setidegrasib. Telix and Regeneron...
467 Views
Thailand Short Interest Weekly (Oct 2nd): Bumrungrad Hospital, Delta Electronics, TISCO Financial
We analyzed SET short interest report for the past week and highlighted short interest changes in Bumrungrad Hospital (BH TB), Delta Electronics...
100 Views
IHH Healthcare (IHH MK): Faster Growth Momentum in 2Q Raises Hope Amid Persisting Legal Headwinds
IHH is facing a legal headwind after a Tokyo Court dismissed its damage claims against Daiichi Sankyo. However, accelerated momentum reported in...
95 Views
APAC Healthcare Weekly (February 15)–Innovent Bio, InSilico, Eisai, Takeda, Alteogen, Pharmaessentia
Few Chinese biotech companies entered drug development collaborations. Eisai’s Leqembi autoinjector gets priority review in China. FDA will likely...
451 Views